Clover Health earns 5-Star Medicare Advantage rating for 2027

WILMINGTON, Del., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), today announced that the Centers for Medicare & Medicaid Services ("CMS") has awarded its PPO Medicare Advantage ("MA") plans a rating of 5 Stars and its HMO MA plan a rating of 4.5 Stars for 2027, which will affect payment year 2028. Through the first half of 2026, Clover Health grew Medicare Advantage membership 48% year-over-year to more than 157,000 members, with 98% enrolled in its wide-network PPO plans. At 5 Stars, Clover's PPO plans will be able to enroll beneficiaries year round. Each year, CMS assigns Star ratings to Medicare Advantage and Part D contracts on its healthcare quality and drug plan, and issues a Star rating on a scale of 1 to 5 Stars. These ratings affect payments to Medicare Advantage plans. For the 2027 Star Ratings, Clover's overall Star rating was driven by improvements across Stars domains. In light of the decision in Clover Insurance Company v. Department of Health & Human Services, Civ. A. No. 25-142 (S.D. Ga.) issued on May 27, 2026, which is on appeal, CMS calculated Clover's rating for its PPO plans removing the 20 measures included in the court decision, awarding Clover's PPO plans 5 Stars. With the 20 measures included, Clover's PPO plans would have received 4.5 Stars. Additionally, for the third year in a row, Clover has continued its market-leading performance on core Healthcare Effectiveness Data and Information Set ("HEDIS(R)"(1) ) measures with a score of 4.82 out of 5 Stars(2), again ranking #1 among non-SNP PPO plans with over 2,000 members. HEDIS is a set of performance measures used to assess aspects of care quality, including preventive screenings and management of health issues such as diabetes, cancer, and heart disease. Clover's HEDIS score remains consistent at 4.82 out of 5 Stars regardless of the CMS methodology used for 2027, demonstrating the strength of a care model powered by Counterpart Assistant that surfaces relevant information for physicians to identify care needs and support better-informed clinical decisions. "Success in the Star ratings system means an enhanced ability to support our members and to continue to provide them market leading plans. We also continue to support reforms to the Stars program that more closely align these ratings with meaningful improvements in members' health and value for the Medicare program," said Andrew Toy, CEO of Clover Health. "We are particularly proud of our core HEDIS measures performance, which assess important aspects of preventive care and chronic disease management. Our focus remains on giving physicians the tools to deliver proactive care across our wide PPO network, supported by our Counterpart Assistant platform." "Our teams have worked incredibly hard over the last several years, and we're excited about what this year's Star rating means for our ability to keep delivering the benefits, afford